Ergoteles LLC Organon & Co. Transaction History

Ergoteles LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $929,449 - $1.19 Million	48,233 New	48,233 $1 Million
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $3.37 Million - $4.14 Million	144,650 Added 1577.77%	153,818 $4.3 Million
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $214,531 - $314,004	9,168 New	9,168 $215,000

786

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.04B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.